-
1.发明申请ARSENIC THERAPY FOR AUTOIMMUNE AND/OR INFLAMMATORY DISEASES IN MICE AND HUMANS 有权用于会议及人体自发性和/或炎症性疾病的ARSENIC治疗公开(公告)号：US20090297624A1
公开(公告)日：2009-12-03
申请号：US12480299
申请日：2009-06-08
Applicant: Kmar Chelbi Alix , Pedro Bobe
Inventor： Kmar Chelbi Alix , Pedro Bobe
CPC classification number: A61K33/36
Abstract: The invention relates to a method for treating and/or preventing autoimmune and/or inflammatory diseases, including the graft-versus-host disease, comprising administering to a patient in need thereof, a therapeutically effective amount of an arsenic compound or a pharmaceutically acceptable salt thereof.
Abstract translation: 本发明涉及用于治疗和/或预防自身免疫性和/或炎症性疾病（包括移植物抗宿主病）的方法，包括向有需要的患者施用治疗有效量的砷化合物或药学上可接受的盐 其中。
-
2.发明申请Arsenic therapy for apls-type autoimmune lymph-oproliferative syndrome in mice and humans 审中-公开用于apls型自身免疫性淋巴细胞增生综合征的小鼠和人类的砷治疗公开(公告)号：US20050163863A1
公开(公告)日：2005-07-28
申请号：US10512430
申请日：2003-04-25
Applicant: Kmar Chelbi Alix , Pedro Bobe
Inventor： Kmar Chelbi Alix , Pedro Bobe
CPC classification number: A61K33/36
Abstract: The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.
Abstract translation: 本发明涉及砷化合物在制备用于治疗自身免疫性疾病的药物中的应用。
-
3.发明授权Arsenic therapy for APLS-type autoimmune lymph-oproliferative syndrome in mice and humans 有权砷治疗APLS型自身免疫性淋巴细胞增生综合征的小鼠和人类公开(公告)号：US08497300B2
公开(公告)日：2013-07-30
申请号：US12244732
申请日：2008-10-02
Applicant: Kmar Chelbi Alix , Pedro Bobe
Inventor： Kmar Chelbi Alix , Pedro Bobe
CPC classification number: A61K33/36
Abstract: The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.
Abstract translation: 本发明涉及砷化合物在制备用于治疗自身免疫性疾病的药物中的应用。
-
4.发明申请ARSENIC THERAPY FOR APLS-TYPE AUTOIMMUNE LYMPH-OPROLIFERATIVE SYNDROME IN MICE AND HUMANS 有权APLS型自身免疫性淋巴细胞性免疫缺陷综合征在人体和人体中的疗效公开(公告)号：US20090098216A1
公开(公告)日：2009-04-16
申请号：US12244732
申请日：2008-10-02
Applicant: Kmar Chelbi Alix , Pedro Bobe
Inventor： Kmar Chelbi Alix , Pedro Bobe
IPC: A61K33/36
CPC classification number: A61K33/36
Abstract: The invention relates to the use of an arsenic compound for the preparation of a medicament that is used to treat autoimmune diseases.
Abstract translation: 本发明涉及砷化合物在制备用于治疗自身免疫性疾病的药物中的应用。
-
-
-
Search Results
4
records
(took 0.009 seconds)
